COMMENTS 0
A European perspective

July welcomes the new financial year and for others, a Euro summer holiday.
July for Medlab was about solidifying our nutraceutical position in the Australian Pharmacy Industry and showcasing both our diabetic and cannabis research with our European peers.
Travelling through Europe provided a solemn reminder that chronic illness knows no boundaries, shows no level of discrimination, and in many cases hides within ignorance.
I witnessed holiday-goers overindulge, simply because it was holidays, nurses self-medicating so they could continue their duties, and Doctors struggling with solutions while patients demanded simple medication to address whatever their problem was.
I lectured on pre and type 2 diabetes as well on cancer pain. The emphasis in both talks was to offer different therapeutic solutions; solutions that may have a vastly improved side effect profile and that may hasten improvements for the patient in question.
The message resonated with the audience, as for many this was their first introduction to Medlab and our work.
Diabetes, as a premise of offering a unique combination of probiotics to address gut health was interesting. Systemic, low grade inflammation took centre stage and I revealed some of our research into a new probiotic used as an adjuvant to metformin.
Clearly, the takeaway was, as medical practitioners we are fighting an uphill battle. Adding new potential to the limited therapeutic offerings is a great start. History has shown us that education lacks results and, for most part, significant lifestyle changes are too hard, complex and/or short lived. But we have a duty of care, we took an oath, and we must navigate the reality of the patient.
This trip emphasised the importance of Medlab, what we are doing and why we are doing it.
More science, more choice, better patient compliance and better health outcomes.
Tell us what you think login to share your thoughts.
ABOUT THE AUTHOR

Dr. Sean Hall
Sean founded Medlab in August 2012; he has over 20 years' experience in nutraceutical sales and development, as well as early drug discovery in Australia, Asia and the US. Sean has led and inspired his teams to author multiple patents, write peer-reviewed articles and deliver lectures at scientific conferences. His passion is leading his researchers into novel areas and strong commercialisation opportunities.
Prior Sean was a founder of FIT-BioCeuticals. Under his management and guidance, BioCeuticals became the most innovative, research-driven, practitioner brand in Australia. For his sale of FIT-BioCeuticals to Blackmores in 2012, Sean was nominated as a finalist in the inaugural Australian Exit CEO of the Year Award. Sean is a Medical Doctor with an MBA in clinical pharmaceutical management and focuses on the research to pioneer innovation and commercialisation. Sean is an active member of Medicines Australia, the European Medical Association, the American Federation for Medical Researcher, The World Medical Association, A4M and Special Operations Medical Association.
MORE BY THIS AUTHOR

Down-scheduling CBD from Schedule 4 to Schedule 3
The TGA’s interim decision to down schedule CBD means some business plans will need to change, but the whole industry stands to benefit.
2020-09-16
Virtual Symposium 2020
Welcome to Medlab Clinical’s first Virtual Symposium where we proudly showcase our scientific endeavours and research achievements. Topics will encompass our core research areas: the applications and distinctions of medicinal cannabis, the microbiome and its influences and the significance and evidence of delivery platforms. Showcasing professional speakers renowned in their respective fields, delegates will have the opportunity to interact live and ask questions at the conclusion of sessions, and thereafter access to session recordings and presentation notes. Attendance to the symposium is free, instead, we kindly encourage delegates to make a donation to the Children’s Cancer Institute to support our joint mission of curing childhood cancer.
2020-07-09
MedSci Doctors discuss - Dosage Forms - Which is Best?
In this raw Un-edited recording, Dr Sean Hall and Dr Luis Vitetta have a conversation on Magnesium, Routes of administration, consumer selection, COVID, In a one to one video link-up Disclaimer - This information may include the views or recommendations of the participants and is not intended to be a substitute for professional or medical advice.
2020-07-08